AOD‑9604 is a high‑purity synthetic peptide derived from a modified fragment of the human growth hormone (HGH) molecule, specifically the 176–191 amino acid sequence. Engineered to mimic the fat‑metabolizing actions of natural HGH without stimulating IGF‑1 or growth‑related pathways, AOD‑9604 is widely used in laboratory and metabolic research for its targeted influence on fat tissue.

This specialized peptide has been studied for its ability to enhance lipolysis (fat breakdown) and inhibit lipogenesis (fat formation) at the cellular level, making it an attractive research tool for investigations into adipose metabolism, body composition, and metabolic health. Unlike full‑length growth hormone, AOD‑9604 offers a focused mechanism of action that allows exploration of fat‑specific signaling and metabolic pathways in vitro and preclinical models.

Researchers appreciate AOD‑9604’s consistent performance, analytical stability, and clear biochemical profile, enabling reproducible studies on lipid metabolism without confounding systemic growth effects. Provided as a lyophilized powder for controlled laboratory use, it should be handled according to recommended safety and storage guidelines.

Key Features:

• Synthetic peptide fragment of human growth hormone (176–191).

• Designed to study fat metabolism and lipolytic pathways.

• Does not stimulate IGF‑1 or systemic growth effects.

• Ideal for metabolic, enzymatic, and biochemical research applications.